Dr. Imus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
401 North Broadway Street
Weinberg BLDG
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-367-2194
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017 - 2019
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011
Certifications & Licensure
MD State Medical License 2014 - 2026
VA State Medical License 2023 - 2026
NC State Medical License 2020 - 2022
NY State Medical License 2013 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Resiliency in Older Adults Undergoing Bone Marrow Transplant Start of enrollment: 2018 Sep 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 99 citationsHaploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide.Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner
Blood Advances. 2020-04-28 - 258 citationsDiagnostic and Prognostic Stratification in the Emergency Department Using Urinary Biomarkers of Nephron Damage: A Multicenter Prospective Cohort StudyThomas L. Nickolas, Kai M. Schmidt-Ott, Pietro A. Canetta, Catherine S. Forster, Eugenia Singer
Journal of the American College of Cardiology. 2012-01-17 - 14 citationsPost-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah
Transplantation and Cellular Therapy. 2022-05-01
Abstracts/Posters
- Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 PatientsPhilip Hollingsworth Imus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- CD38 Knockout Primary NK Cells to Prevent Fratricide and Boost Daratumumab ActivityPhilip Hollingsworth Imus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
